Septra

Septra

Dosage
400/80mg 800/160mg
Package
360 pill 270 pill 180 pill 120 pill 90 pill 60 pill 30 pill 20 pill 10 pill
Total price: 0.0
  • In Canada Septra (co‑trimoxazole) is Health Canada–authorized and is normally sold by prescription in pharmacies; it is available as tablets, suspensions and, in some markets, IV vials. Note: in some jurisdictions or from some online sellers it may sometimes be obtained without a prescription (not recommended and may be unlawful).
  • Septra is used to treat urinary tract infections, acute otitis media in children, bronchitis, traveler’s diarrhoea, shigellosis and for Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment. Mechanism: sulfamethoxazole inhibits dihydropteroate synthase and trimethoprim inhibits dihydrofolate reductase, producing a synergistic blockade of bacterial folate synthesis.
  • Usual dosage: adults with uncomplicated UTI — one DS tablet (800 mg SMX/160 mg TMP) every 12 hours; pediatric dosing typically 8 mg/kg TMP + 40 mg/kg SMX divided q12h (use suspension); PCP treatment 15–20 mg/kg TMP per day divided q6–8h; PCP prophylaxis often 1 DS tablet once daily or three times weekly. Adjust dose for renal impairment and specific indications.
  • Forms of administration: oral tablets (400/80 mg and 800/160 mg DS), oral suspension (200 mg SMX/40 mg TMP per 5 mL), and intravenous formulation in some hospital settings.
  • Onset time: the drugs reach peak blood levels in about 1–4 hours; symptomatic or clinical improvement is commonly seen within 24–72 hours depending on the infection.
  • Duration of action: standard dosing provides roughly 12 hours of therapeutic coverage per dose (hence usual q12h dosing); prophylactic regimens may be given once daily or on alternative schedules as prescribed.
  • Alcohol warning: avoid excessive alcohol while taking Septra — alcohol may worsen side effects such as gastrointestinal upset and may increase risk to the liver; limiting or avoiding alcohol is advisable.
  • The most common side effect is nausea (other frequent effects include vomiting, rash, headache, hyperkalemia and mild liver enzyme elevations).
  • Would you like to try “septra” without a prescription?
Trackable delivery 5-9 days
Payment method Visa, MasterCard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Basic Septra Information

  • INN (International Nonproprietary Name): Sulfamethoxazole and Trimethoprim.
  • Brand Names Available In Canada (English): Apo-Sulfatrim, Novo-Trimel, Nu-Cotrimox, Septra Pediatric Suspension.
  • ATC Code: J01EE01.
  • Forms & Dosages: Tablets 400 mg SMX/80 mg TMP and 800 mg SMX/160 mg TMP (DS); suspension 200 mg SMX/40 mg TMP per 5 mL; IV formulation 80 mg TMP/400 mg SMX per 5 mL vial.
  • Manufacturers In Canada (English): Products supplied in Canada include generics from Apotex and Teva among others.
  • Registration Status In Canada (English): Rx only and Health Canada authorized.
  • OTC / Rx Classification: Rx Only.

Latest Research Highlights

Patients often ask whether resistance or safety concerns mean septra is outdated.

Recent surveillance (2022–2025) in Canada and similar jurisdictions continues to support co‑trimoxazole for uncomplicated urinary tract infection and for Pneumocystis jirovecii pneumonia prophylaxis and treatment.

Health Canada safety advisories and international pharmacovigilance updates emphasise serious hypersensitivity and hematologic risks as ongoing concerns.

Regional surveillance reports cited rising resistance among some enteric pathogens in parts of North America and Europe, prompting re‑evaluation of empirical therapy in those areas.

There is a clear gap in Canadian randomised head‑to‑head trials comparing co‑trimoxazole with nitrofurantoin and pivmecillinam for uncomplicated UTI.

Study Region Year Population Outcome (Clinical Cure) Resistance %
Canada 2022–2025 Not specified Not specified Not specified
United States 2022–2025 Not specified Not specified Not specified
Europe 2022–2025 Not specified Not specified Not specified

Major safety signals to watch for include Stevens‑Johnson syndrome and toxic epidermal necrolysis, and laboratory trends such as hyperkalemia and bone marrow suppression.

In rural and Indigenous communities where culture results can be delayed, clinicians are advised to rely on local antibiograms and stewardship guidance when choosing empiric therapy.

Suggested research priorities for Canada include updated provincial antibiograms and real‑world pharmacoepidemiology on adverse events and comparative effectiveness.

  • Research Gap: More Canadian RCTs comparing co‑trimoxazole vs nitrofurantoin and pivmecillinam for uncomplicated UTI.
  • Research Gap: Provincial, up‑to‑date antibiograms with community prescribing linkage.
  • Research Gap: Real‑world pharmacoepidemiology on severe cutaneous adverse reactions and hematologic toxicity in Canadian populations.

Data Highlight: Pharmacovigilance continues to flag severe hypersensitivity and hematologic events including SJS/TEN and hyperkalemia.

Clinical Effectiveness In Canada

Patients want to know when septra actually works well.

INN is sulfamethoxazole and trimethoprim, classified under ATC J01EE01.

In Canada the drug is authorised in tablet and suspension forms under brand names such as Apo‑Sulfatrim, Novo‑Trimel, Nu‑Cotrimox and Septra Pediatric Suspension.

Strong evidence supports use in uncomplicated urinary tract infections at double‑strength dosing and for PCP prophylaxis and treatment.

Indication Typical Canadian Dosing Typical Duration
Uncomplicated UTI 1 DS tab (800/160 mg) q12h 3–14 days
Pneumocystis Jirovecii Pneumonia (Prophylaxis) 1 DS tab q24h or q3x/week As long as risk persists
Pneumocystis Jirovecii Pneumonia (Treatment) 15–20 mg/kg TMP/day divided q6–8h 14–21 days
Shigellosis 1 DS tab q12h 5 days
Prophylaxis
Use to prevent infection while risk persists, for example in immunosuppressed patients.
Treatment
Higher, weight‑based or more frequent dosing to eradicate an active infection, for example PCP treatment.
  • Top Indications: UTI, PCP prophylaxis/treatment, shigellosis, selected respiratory infections.
  • Clinician Note: Check local antibiogram and renal function before prescribing.

Health Canada classifies septra as Rx‑only, and individual products carry a DIN and may appear on provincial formularies.

Patients in rural areas who use multi‑day prescriptions from community pharmacies such as Shoppers Drug Mart, Rexall, London Drugs or Jean Coutu often face adherence challenges with twice‑daily dosing, so counselling on timing is important.

Indications And Expanded Uses

People often ask which uses are standard and which are off‑label.

Indication Approved? Typical Canadian Regimen Notes
Urinary Tract Infection Yes 1 DS tab q12h Duration 3–14 days depending on severity.
Pneumocystis Jirovecii Pneumonia (Prophylaxis) Yes 1 DS tab q24h or q3x/week Continue while risk persists.
Pneumocystis Jirovecii Pneumonia (Treatment) Yes 15–20 mg/kg TMP/day divided q6–8h Treatment 14–21 days.
Shigellosis Yes 1 DS tab q12h 5 day course in typical cases.
Traveller’s Diarrhea / Bronchitis Situational/Off‑Label 1 DS tab q12h, 5–14 days Depends on local resistance patterns.
  • Common Off‑Label Uses: Certain traveller’s diarrheas where local resistance is low, and some paediatric respiratory infections when indicated by weight‑based dosing.
DS
Double Strength tablet containing 800 mg sulfamethoxazole and 160 mg trimethoprim.
Weight‑Based Pediatric Dosing
Typically 8 mg/kg TMP plus 40 mg/kg SMX per dose divided every 12 hours for many pediatric indications.

Contraindications include pregnancy near term, infants under two months, and severe renal or hepatic impairment, which are absolute per product labelling.

Patients should check their provincial formularies such as ODB, PharmaCare or RAMQ for coverage and local pharmacy availability.

Composition And Brand Landscape

Patients often ask whether brand name matters for septra.

Active ingredients are sulfamethoxazole and trimethoprim, commonly referred to as co‑trimoxazole.

Brand Formulation Strength Typical Packaging
Apo‑Sulfatrim Tablet 400/80 mg; 800/160 mg (DS) Blister packs or bottles
Novo‑Trimel Tablet 400/80 mg; 800/160 mg (DS) Bottles/blisters
Nu‑Cotrimox Tablet 400/80 mg; 800/160 mg (DS) Bottles
Septra Pediatric Suspension Oral Suspension 200 mg SMX / 40 mg TMP per 5 mL 50–100 mL bottles
  • Available Forms: Tablets, suspension, and IV formulations in some hospital settings.
  • Manufacturers Supplying Canadian Market: Apotex, Teva and other generics manufacturers.

Each marketed product in Canada has a DIN and bilingual labelling in English and French.

Data Highlight: Double‑strength tablets are commonly used in outpatient prescribing for UTI.

Generics are common and typically less expensive, so patients should check provincial drug plans for preferred products.

Contraindications And Special Precautions

Patients should be clear on who should not take septra and why.

Known Allergy To Sulfonamides Or Trimethoprim
Absolute contraindication due to risk of severe hypersensitivity reactions.
Severe Renal Or Hepatic Impairment
Avoid or use with close monitoring; dosing adjustments required for renal impairment and avoid if CrCl <15 mL/min.
Megaloblastic Anaemia Due To Folate Deficiency
Contraindicated because folate antagonism may worsen anaemia.
Infants <2 Months
Contraindicated due to risk of kernicterus and other complications.
Pregnancy And Breastfeeding
Avoid especially near term; discuss alternatives with prescriber.
  • Relative Cautions: G6PD deficiency risk of haemolysis, elderly patients due to hyperkalemia risk, and patients with haematologic disorders or porphyria.
  • Monitoring Suggestions: Baseline renal function, electrolytes including potassium, and CBC for prolonged therapy or high‑risk patients.

Data Highlight: Monitor for hyperkalemia and bone marrow suppression during therapy, especially in elderly or renally impaired patients.

When To Avoid Use Reason
Pregnancy Near Term Risk to neonate and folate antagonism.
Infant <2 Months Risk of kernicterus and adverse effects.
Severe Renal Impairment Accumulation and toxicity; avoid if CrCl <15 mL/min.

For patients in remote or Indigenous communities with limited lab access, consider alternative agents or arrange remote monitoring with provincial telehealth or local nursing services.

Dosage Guidelines

Clear dosing helps reduce errors.

Indication Adult Dose Pediatric Dose Renal Adjustment
Uncomplicated UTI 1 DS tab (800/160 mg) q12h 8 mg/kg TMP + 40 mg/kg SMX divided q12h Reduce dose for renal impairment; avoid if CrCl <15 mL/min
PCP Treatment 15–20 mg/kg TMP/day divided q6–8h Weight‑based equivalent Careful monitoring and adjustment required
  • Practical Counselling: Measure suspension with the provided syringe and reconstitute per label instructions.
  • Storage: Store tablets and suspension at room temperature (20–25°C) and protect suspension from light.
  • Missed Dose Guidance: Take as soon as remembered unless near the next dose, then skip; do not double doses.

Elderly patients should have renal function checked and potassium monitored during therapy.

Clinicians should consult provincial formularies for available strengths and whether DS tablets are preferred for outpatient prescribing.

Interactions Overview

Drug interactions are an important safety topic for patients on multiple medications.

Interacting Drug/Class Effect Monitoring/Action
Warfarin Increased INR and bleeding risk Check INR frequently and adjust warfarin dose as needed
ACE Inhibitors/ARBs, Potassium‑Sparing Diuretics Increased risk of hyperkalemia Monitor serum potassium and renal function
Methotrexate Potential potentiation and toxicity Avoid combination or monitor levels closely
Sulfonylureas Increased hypoglycaemia risk in older adults Monitor blood glucose closely
  • Food/Drink Interactions: No major food restrictions, but stay well hydrated for UTI treatment.
  • Pharmacist Role: Community pharmacies such as Shoppers Drug Mart and Rexall run interaction checks at dispensing.

Rural patients often rely on phone counselling, so clearly communicate the risks with warfarin and methotrexate and document any monitoring plans.

Cultural Perceptions And Patient Habits

Patients commonly worry about antibiotic overuse and whether brand matters.

Canadian patients generally prefer generics for cost reasons and expect bilingual labelling and clear counselling.

Public sentiment values antimicrobial stewardship, and many people raise allergy and side‑effect concerns in online forums and patient groups.

  • Access Differences: Urban residents have easier access to major pharmacy chains while rural residents may rely on local clinics or flying nurse services.
  • Indigenous Care Contexts: Telehealth and local community health workers are often key to safe monitoring and follow‑up.
  • Preferred Counselling Messages: Clear explanations about allergy checks, side effects to watch for, and the importance of completing the full course.
Empiric Therapy
Starting antibiotic treatment based on likely pathogens before culture results.
Targeted Therapy
Adjusting antibiotic choice based on culture and sensitivity results.

Clinician Tip: Provide bilingual (English/French) patient handouts and coordinate lab follow‑up for remote patients.

Availability And Pricing Patterns

Availability and cost matter when choosing therapy.

Product Common Retail Availability Form Typical Canadian Sourcing Note
Apo‑Sulfatrim Major pharmacy chains Tablet Generic supplier in Canada
Septra Pediatric Suspension Community pharmacies Oral suspension Often stocked for paediatric prescriptions
Nu‑Cotrimox Selected pharmacies Tablet Generic distribution
  • Pricing Patterns: Generics are usually less expensive but prices vary by province and pharmacy.
  • Cross‑Border Considerations: Some patients compare U.S. prices, but must consider prescription and import rules.
  • Online Pharmacies: Patients should confirm Canadian licensure and DIN when ordering online.

Data Highlight: Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list preferred products or require prior authorization for certain indications.

In our online pharmacy, septra is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Comparable Medicines And Preferences

When septra is not suitable, clinicians often choose alternatives.

  • Nitrofurantoin: Preferred for uncomplicated lower UTI when local resistance allows and renal function permits.
  • Trimethoprim Alone: Narrower spectrum and alternative for UTI in some cases.
  • Ciprofloxacin: Reserved for specific indications due to collateral damage and stewardship concerns.
  • Alternative Agents For PCP: Used when co‑trimoxazole intolerance or contraindications exist.
Drug Typical Indication Pros Cons Provincial Coverage Notes
Nitrofurantoin Uncomplicated UTI Good activity for lower UTI, less impact on gut flora Not suitable for pyelonephritis or CrCl <30 mL/min Often listed on provincial formularies for UTI
Trimethoprim UTI Simpler formulation Resistance concerns in some regions Generic options available
Ciprofloxacin Complicated UTI, some enteric infections Broad spectrum and effective for many pathogens Collateral damage and stewardship restrictions May require justification in some formularies

Pharmacist Tip: Review DINs and formulary status before substituting and counsel patients on allergy differences when sulfa allergy excludes co‑trimoxazole.

FAQ Section

Q1: Is Septra the same as Bactrim?

A1: Yes, both contain sulfamethoxazole/trimethoprim (co‑trimoxazole) and the active ingredients are the same.

  • Brand Equivalents: Septra, Bactrim, Apo‑Sulfatrim, Novo‑Trimel, Nu‑Cotrimox.

Q2: Can I get Septra without a prescription in Canada?

A2: No, septra is Rx only per Health Canada, and pharmacists cannot legally supply it without a prescription.

Data Highlight: Rx only status applies across major markets.

Q3: Is it safe in pregnancy or breastfeeding?

A3: Septra is generally avoided in pregnancy especially near term, and alternatives should be discussed with the prescriber.

Pregnancy Considerations
Discuss timing, risks and alternative antibiotics with your healthcare provider.

Q4: What should I watch for while taking it?

A4: Watch for rash, gastrointestinal upset, signs of allergic reaction, increased bruising or bleeding, weakness or palpitations that may indicate hyperkalemia.

  • Red Flags: Severe rash, jaundice, shortness of breath, sudden bleeding or unexplained bruising — seek immediate care.

Patients should check provincial drug plans such as ODB, PharmaCare or RAMQ for coverage and ask their pharmacist at Shoppers or Rexall about generic options.

Guidelines For Proper Use

Clear guidance reduces errors and adverse effects.

  • Complete the full course as prescribed even if symptoms improve.
  • Take tablets with a full glass of water and space doses evenly for twice‑daily regimens.
  • Measure suspension with the provided syringe and do not freeze reconstituted suspension.

Monitoring Checklist:

  • Baseline renal function before starting therapy if risk factors present.
  • Serum electrolytes, particularly potassium, in elderly or renally impaired patients.
  • CBC for prolonged therapy or patients at risk of hematologic toxicity.
  • INR monitoring when co‑administered with warfarin.

Missed Dose Advice: Take as soon as remembered unless it is nearly time for the next dose, and never double doses.

Overdose Advice: Seek emergency care; overdose may cause nausea, confusion, bone marrow suppression or hyperkalemia and dialysis may be considered in severe cases.

Pharmacy Workflow Tips: Confirm DIN at dispensing, document bilingual counselling, and check provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ for prior authorisation requirements.

Remote Care Tip: Arrange lab monitoring via local health centres or telepharmacy and coordinate with community health nurses for patients in remote or Indigenous communities.

Data Highlight: Store tablets and suspension at room temperature (20–25°C) and protect the suspension from light; do not freeze reconstituted product.

Delivery Across Canada (English)

City Region Delivery Time
Toronto Ontario 5-7 days
Vancouver British Columbia 5-7 days
Montreal Quebec 5-7 days
Calgary Alberta 5-7 days
Edmonton Alberta 5-7 days
Ottawa Ontario 5-7 days
Winnipeg Manitoba 5-7 days
Quebec City Quebec 5-7 days
Halifax Nova Scotia 5-7 days
Victoria British Columbia 5-7 days
Saskatoon Saskatchewan 5-9 days
Regina Saskatchewan 5-9 days
London Ontario 5-9 days
St. John's Newfoundland and Labrador 5-9 days
Hamilton Ontario 5-9 days